Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wolters

Showing results (191-200 of 210) with videos related to

Pageof 21
Sort By:
Immunity|June 1, 2024
Isolation of human antibodies against influenza B neuraminidase and mechanisms of protection at the airway interfaceRachael M Wolters, James A Ferguson, Ivette A Nuñez, et al.
Gut|September 9, 2011
NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2Aleixo M Muise, Wei Xu, Cong-Hui Guo, et al.
Human Molecular Genetics|December 17, 2013
Fine mapping of the celiac disease-associated LPP locus reveals a potential functional variantRodrigo Almeida, Isis Ricaño-Ponce, Vinod Kumar, et al.
NPJ Breast Cancer|January 20, 2024
Predicting response to neoadjuvant chemotherapy with liquid biopsies and multiparametric MRI in patients with breast cancerL M Janssen, M H A Janse, B B L Penning de Vries, et al.
Alimentary Pharmacology & Therapeutics|April 22, 2024
Randomised clinical trial: First-line infliximab biosimilar is cost-effective compared to conventional treatment in paediatric Crohn's diseaseStephanie A Vuijk, Maria M E Jongsma, Britt M Hoeven, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 4, 2026
Randomized trial comparing 5-year follow-up of first-line infliximab to conventional therapy in paediatric Crohn's diseaseS A Vuijk, M M E Jongsma, M A Cozijnsen, et al.
Gastroenterology|June 21, 2011
Single nucleotide polymorphisms that increase expression of the guanosine triphosphatase RAC1 are associated with ulcerative colitisAleixo M Muise, Thomas Walters, Wei Xu, et al.
Gut|January 1, 2021
First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre randomised controlled trialMaria M E Jongsma, Martine A Aardoom, Martinus A Cozijnsen, et al.
Vaccine|May 17, 2023
Meningococcal ACWY conjugate vaccine immunogenicity and safety in adolescents with juvenile idiopathic arthritis and inflammatory bowel disease: A prospective observational cohort studyMilou Ohm, Joeri W van Straalen, Marieke Zijlstra, et al.
Clinical Nutrition (Edinburgh, Scotland)|January 28, 2019
Potentially modifiable determinants of malnutrition in older adults: A systematic reviewM O'Keeffe, M Kelly, E O'Herlihy, et al.
Pageof 21

Showing results (191-200 of 210) with videos related to

Sort By:
Pageof 21
Immunity|June 1, 2024
Isolation of human antibodies against influenza B neuraminidase and mechanisms of protection at the airway interfaceRachael M Wolters, James A Ferguson, Ivette A Nuñez, et al.
Gut|September 9, 2011
NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2Aleixo M Muise, Wei Xu, Cong-Hui Guo, et al.
Human Molecular Genetics|December 17, 2013
Fine mapping of the celiac disease-associated LPP locus reveals a potential functional variantRodrigo Almeida, Isis Ricaño-Ponce, Vinod Kumar, et al.
NPJ Breast Cancer|January 20, 2024
Predicting response to neoadjuvant chemotherapy with liquid biopsies and multiparametric MRI in patients with breast cancerL M Janssen, M H A Janse, B B L Penning de Vries, et al.
Alimentary Pharmacology & Therapeutics|April 22, 2024
Randomised clinical trial: First-line infliximab biosimilar is cost-effective compared to conventional treatment in paediatric Crohn's diseaseStephanie A Vuijk, Maria M E Jongsma, Britt M Hoeven, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 4, 2026
Randomized trial comparing 5-year follow-up of first-line infliximab to conventional therapy in paediatric Crohn's diseaseS A Vuijk, M M E Jongsma, M A Cozijnsen, et al.
Gastroenterology|June 21, 2011
Single nucleotide polymorphisms that increase expression of the guanosine triphosphatase RAC1 are associated with ulcerative colitisAleixo M Muise, Thomas Walters, Wei Xu, et al.
Gut|January 1, 2021
First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre randomised controlled trialMaria M E Jongsma, Martine A Aardoom, Martinus A Cozijnsen, et al.
Vaccine|May 17, 2023
Meningococcal ACWY conjugate vaccine immunogenicity and safety in adolescents with juvenile idiopathic arthritis and inflammatory bowel disease: A prospective observational cohort studyMilou Ohm, Joeri W van Straalen, Marieke Zijlstra, et al.
Clinical Nutrition (Edinburgh, Scotland)|January 28, 2019
Potentially modifiable determinants of malnutrition in older adults: A systematic reviewM O'Keeffe, M Kelly, E O'Herlihy, et al.
Pageof 21